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FOXO transcription factors are central regulators of
longevity from worms to humans. FOXO3, the
FOXO isoform associated with exceptional human
longevity, preserves adult neural stem cell pools.
Here, we identify FOXO3 direct targets genome-
wide in primary cultures of adult neural progenitor
cells (NPCs). Interestingly, FOXO3-bound sites are
enriched for motifs for bHLH transcription factors,
and FOXO3 shares common targets with the pro-
neuronal bHLH transcription factor ASCL1/MASH1
in NPCs. Analysis of the chromatin landscape reveals
that FOXO3 and ASCL1 are particularly enriched at
the enhancers of genes involved in neurogenic path-
ways. Intriguingly, FOXO3 inhibits ASCL1-dependent
neurogenesis in NPCs and direct neuronal conver-
sion in fibroblasts. FOXO3 also restrains neuro-
genesis in vivo. Our study identifies a genome-wide
interaction between the prolongevity transcription
factor FOXO3 and the cell-fate determinant ASCL1
and raises the possibility that FOXO3’s ability to
restrain ASCL1-dependent neurogenesis may help
preserve the neural stem cell pool.
INTRODUCTION
FOXO transcription factors promote longevity downstream of
the insulin/IGF-1 signaling pathway from worms to mammals
(Kenyon, 2010). When the insulin/insulin-like growth factor(IGF) 1 signaling pathway is inactive, FOXO transcription factors
translocate to the nucleus, where they act mostly as transcrip-
tional activators (Calnan and Brunet, 2008). Overexpression of
FOXO transcription factors extends lifespan in invertebrates
(Giannakou et al., 2004; Henderson and Johnson, 2001;
Hwangbo et al., 2004). In humans, FOXO3, one of the four
FOXO family members, has been associated with exceptional
lifespan in eight cohorts of centenarians (Kenyon, 2010). Inter-
estingly, FOXO3 has recently been found to regulate adult neural
stem cells (NSCs) and hematopoietic stem cells (HSCs). FOXO3
is localized in the nucleus of NSCs and HSCs in vivo (Miyamoto
et al., 2007; Paik et al., 2009; Renault et al., 2009), suggesting
that FOXO3 is active in these cells. Deletion of the Foxo3 gene
in mice leads to the premature depletion of NSCs and HSCs in
adult animals (Miyamoto et al., 2007; Paik et al., 2009; Renault
et al., 2009; Tothova et al., 2007). Combined deletion of Foxo1,
Foxo3, and Foxo4 leads to a more pronounced depletion of
NSCs and HSCs in vivo (Paik et al., 2009; Tothova et al., 2007),
indicating that FOXO transcription factors have overlapping roles
in maintaining adult stem cell pools in vivo. The ability of FOXO
transcription factors to regulate adult stem cell homeostasis is
likely to be crucial for tissue regeneration, and potentially organ-
ismal longevity.
Although the importance of FOXO3 in stem cell maintenance is
well known, the role of FOXO3 in the differentiation of stem and
progenitor cells has been less explored. In vivo, the loss of FOXO
transcription factors causes a premature burst in neurogenesis
during development (Paik et al., 2009), raising the possibility
that FOXO factors inhibit neuronal differentiation. However, the
importance of FOXO3 in the neuronal differentiation of neural
stem and progenitor cells and the specific FOXO3 targets
that may affect this neuronal differentiation have not beenCell Reports 4, 477–491, August 15, 2013 ª2013 The Authors 477
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established. Given the importance of neural stem and progenitor
cells for the generation of new neurons, and their potential use
for regenerative medicine, understanding the mechanisms by
which FOXO3 acts in cells from the neural lineage should provide
important insight into the regulation of these cells and their ability
to produce new neurons.
FOXO3 is well known to regulate gene expression programs
that coordinate stress resistance, cell-cycle progression, auto-
phagy, and apoptosis (Salih and Brunet, 2008), but the ensemble
of direct target genes of FOXO3 are still largely unknown.
Although recent studies have characterized FOXO1 and
FOXO3 targets in a few differentiated lineages (Lin et al., 2010;
Litvak et al., 2012; Ouyang et al., 2012; Shin et al., 2012), the
direct FOXO3 targets have never been characterized in a stem/
progenitor context. Furthermore, the mode of action of FOXO
transcription factors in specific lineages is largely unknown.
Finally, whether FOXO3 shares targets with other transcription
factors genome-wide has never been determined in stem/pro-
genitor cells.
Here, we use primary cultures of adult neural progenitor cells
(NPCs) as a cellular system to understand FOXO3’smechanisms
of action in the neural lineage. We find that FOXO3 can bind
about 2,000 direct targets genome-wide in these cells.
FOXO3-bound genes extensively overlap with those bound by
the proneuronal bHLH transcription factor ASCL1/MASH1 in
cultured NPCs. Genome-wide analysis of the chromatin land-
scape in these cells reveals that FOXO3 and ASCL1 are enriched
at enhancer regions. Interestingly, FOXO3 represses the expres-
sion of a subset of ASCL1 neurogenic targets and restrains
neurogenesis in vitro and in vivo. FOXO3 also inhibits the
ability of ASCL1 to directly reprogram fibroblasts into induced
neurons (iNs). These findings suggest that FOXO3 can act by
repressing the transcriptional activity of a ‘‘master regulator’’ of
cell fate. Thus, FOXO3may help preserve an intact pool of neuralFigure 1. Genome-wide Identification of FOXO3 Binding Sites in Adult
(A) Low-passage adult NPCs were cultured in high growth factor signaling (HGF
growth factor signaling (LGFS) conditions to induce FOXO3 nuclear accumulatio
(B) ChIP-qPCR analysis of FOXO3 binding to the known target gene Cdkn1b (p
signaling (LGFS) conditions. Neg C, negative control (genomic primers that amplif
experiment of two independent experiments. Enrichment is calculated relative to
(C) Numbers of unique Solexa reads, QuEST peaks, corresponding RefSeq gen
ChIP from adult NPCs. N/A, not applicable; HGFS, high growth factor signaling;
(D) UCSC Genome Browser shot showing FOXO3 binding at the Pot1a locus. F
respectively. Normalized QuEST peaks (blue), binding region (light blue), and bin
(E) List of the ten FOXO3-bound genes in adult NPCs with the highest QuEST sc
(F) FOXO3 binding sites identified byChIP-seq are specific FOXO3 binding sites in
growth factor signaling (LGFS) conditions. QuEST scores are indicated in purpl
quartile and two targets from each of the bottom quartiles are shown. Mean ± SD o
control region of the genome. ***p < 0.001, **p < 0.01, Two-way ANOVA, Bonfer
(G) FOXO3 ChIP-qPCR in adult neurogenic niches (subventricular zones [SVZs])
dependent experiments. Enrichment is calculated relative to input. *p < 0.05, Two
are presented in Figure S2C.
(H) Regression analysis comparing FOXO3 ChIP enrichments in vivo in the SVZ
p value = 3.8 3 106.
(I) Expression of top FOXO3-bound genes in vivo in FACS-purified astrocytes, a
technical replicates of one representative experiment of two independent experim
S2D–S2F.
(J) Overlap between FOXO3-bound genes and genes that are downregulated in
See also Figures S1, S2, and S3 and Tables S1, S2, and S3.stem cells at least in part by negatively regulating neuronal
differentiation.
RESULTS
Genome-wide Identification of FOXO3 Binding Sites in
Adult Neural Progenitor Cells
To identify FOXO3 binding sites genome-wide in a stem/progen-
itor context, we used primary cultures of adult NPCs. We chose
these cells because they can differentiate into neurons, astro-
cytes, and oligodendrocytes (albeit with a bias toward astro-
cytes) (Pastrana et al., 2011), and they can be expanded in
culture to provide cell numbers (10–100million) that are compat-
ible with chromatin immunoprecipitation followed by next gener-
ation sequencing (chromatin immunoprecipitation sequencing
[ChIP-seq]). We performed FOXO3 ChIP-seq in these primary
cultures of NPCs before and after the induction of FOXO3
nuclear localization (Figure 1A), as FOXO3 is mostly localized
in the nucleus of NSCs in vivo (Figure S1A) (Paik et al., 2009;
Renault et al., 2009). To induce FOXO3 nuclear localization, we
transiently incubated NPCs in conditions of low growth factor
signaling (Experimental Procedures). These conditions have
been used previously for FOXO3 ChIP-qPCR in cultured NPCs
(Renault et al., 2009) and other cellular systems (van der Vos
et al., 2012). Using immunofluorescence, we verified that a
tagged version of FOXO3 indeed accumulates in the nucleus
of NPCs in low growth factor signaling conditions (Figures S2A
and S2B). Following translocation to the nucleus, endogenous
FOXO3 is indeed recruited to Cdkn1b (p27), a well-known
FOXO target gene, in cultured NPCs (Figure 1B). Under these
experimental conditions, greater than 90% of the NPCs still ex-
press the neural progenitor markers NESTIN and SOX2 (Figures
S1B–S1F) and retain the ability to differentiate into neurons (Fig-
ure S1G). Thus, primary cultures of adult NPCs in low growthNPCs
S) conditions (FOXO3 mostly cytoplasmic) or were transiently cultured in low
n.
27) in NPCs in high growth factor signaling (HGFS) versus low growth factor
y a region not bound by FOXO3). Mean ± SD of triplicates of one representative
the negative control region of the genome.
es, unique gene symbols, and QuEST false discovery rates (FDRs) for FOXO3
LGFS, low growth factor signaling.
orward and reverse ChIP-seq sequence tags are shown in yellow and green,
ding site (red) are shown below the sequence tags.
ores. Enrichment values by ChIP-qPCR are indicated on the right.
NPCs. ChIP-qPCR inNPCs from adult Foxo3+/+ and Foxo3/ littermates in low
e. Based on QuEST enrichment, three FOXO3 targets from the top ChIP-seq
f two independent experiments. Enrichment is calculated relative to a negative
roni correction. Neg C, negative control.
that were microdissected from 3- to 6-month-old mice. Mean ± SD of two in-
-way ANOVA, Bonferroni correction. Neg C, negative control. Additional genes
versus ChIP-seq peak height in cultured NPCs. Pearson correlation, R = 0.94,
ctivated NSCs, and NPCs freshly isolated from the adult brain. Mean ± SD of
ents. Validation of the FACS strategy and additional genes are shown in Figures
Foxo3/ NPCs by microarray analysis (Fisher’s exact test, p = 1.18 3 1017).
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factor signaling conditions provide a cellular system to identify
FOXO3 direct targets in a stem/progenitor context.
To characterize the ensemble of FOXO3 direct targets in
NPCs, we performed FOXO3 ChIP-seq. FOXO3 binding sites
were identified using QuEST (Valouev et al., 2008) with a strin-
gent false discovery rate threshold (FDR < 0.001) (Figure 1C).
Prior to induction of nuclear translocation, FOXO3 was, as ex-
pected, bound to very few genomic regions (eight) (Figure 1C).
In contrast, following nuclear translocation, FOXO3 was bound
to 4,329 genomic regions (QuEST peaks), 2,291 of which were
within 5 kb of unique RefSeq genes (Figure 1C). An example of
FOXO3 binding is shown in Figure 1D. The ten FOXO3-bound
genes with the highest QuEST binding scores are listed in Fig-
ure 1E (complete data sets are in Tables S1 and S2). We verified
that genes bound by FOXO3 in ChIP-seq experiments were also
bound by ChIP-qPCR in wild-type NPCs, but not in Foxo3/
NPCs (Figure 1F). Thus, FOXO3 binds to approximately 2,000
genes in cultured NPCs under low growth factor signaling
conditions.
We next asked if FOXO3 also binds these target genes in vivo.
We performed FOXO3 ChIP-qPCR on microdissected neuro-
genic niches (subventricular zones [SVZs]), which are enriched
for neural stem and progenitor cells in the adult mouse.We found
that endogenous FOXO3 was bound to several of its targets
(Pot1a, Arrdc3, Akt1s1/Tbc1d17, Txnip, Hbp1, and Vkorc1) in
neurogenic niches (Figures 1G and S2C; Table S1). Of the
genes tested (12), half validated in vivo and are likely to represent
bona fide FOXO3 targets. A regression analysis showed that
FOXO3 binding enrichments in vitro and in vivo were significantly
correlated (Figure 1H, Pearson correlation, R = 0.94, p = 3.8 3
1006), indicating that genes that have the highest enrichment
for FOXO3 in culture are more likely to be bound by FOXO3
in vivo. Importantly, the FOXO3-bound genes that validated
in vivo were indeed expressed in activated NSCs and NPCs
freshly purified from the adult brain using a fluorescence-acti-
vated cell sorting (FACS) strategy (Pastrana et al., 2009) (Figures
1I and S2D–S2F).
FOXO3-bound genes in cultured NPCs significantly overlap-
ped with genes that are downregulated in Foxo3/ NPCs (Fig-
ure 1J, Fisher’s exact test, p = 1.18 3 1017). This observation,
coupled with the fact that FOXO3 is known to act as a transcrip-
tional activator (Calnan and Brunet, 2008; Salih and Brunet,
2008), provides further support for the relevance of the FOXO3
ChIP-seq data set. FOXO3 could also act as a transcriptional
repressor at some specific targets, although this was not statis-
tically significant (Figure S2G). Interestingly, FOXO3 binding sites
in NPCs significantly overlapped with FOXO1 and FOXO3 bind-
ing sites in other cell types (B cells, T cells, macrophages) (Fig-
ures S3A–S3D; Table S3), indicating that there exists a ‘‘core
set’’ of FOXO targets as well as lineage/cell-specific FOXO tar-
gets (Figure S3D; Table S3). Collectively, these results are
consistent with the notion that the FOXO3 target genes identified
in cultured NPCs have physiological relevance.
In SilicoMotif Analysis for FOXO3Binding Reveals FOXO
and bHLH Binding Sites
We asked whether FOXO3 co-occurs with other transcription
factors genome-wide. De novo motif analysis of FOXO3 ChIP-480 Cell Reports 4, 477–491, August 15, 2013 ª2013 The Authorsseq data sets using the MEME motif finder (Bailey and Elkan,
1994) revealed that 90% of FOXO3-bound sites contained the
FOXO consensus motif TGTTTAC (E value = 1.53 103175) (Fig-
ure 2A) (Furuyama et al., 2000), confirming that FOXO3 binding
sites in NPCs are bona fide recruitment sites for this transcription
factor. Interestingly, analysis of the 200 bp regions surrounding
the FOXO3 ChIP-seq peaks revealed two other motifs that co-
occur with FOXO3 binding sites: a CAGCTG motif which co-
occurs at more than 30% of the binding sites (E value = 2.5 3
10406) (Figure 2B) and a CAGGCTG motif that co-occurs at
about 30% of the binding sites (E value = 3.1 3 10273) (data
not shown). Analysis by STAMP (Mahony and Benos, 2007)
revealed that the CAGCTG motif is a specific subclass of
E-box consensus sites (Powell and Jarman, 2008). These
E boxes are known to be bound by bHLH transcription factors
that have been called ‘‘master regulators’’ of cell identity,
including ASCL1/MASH1, NEUROD1, NGN1, and MYOD (Fig-
ure 2C) (Guillemot, 1999; Hu et al., 2004). Such transcription fac-
tors are sufficient to promote cell differentiation and even direct
reprogramming of a differentiated cell type into another (Vierbu-
chen and Wernig, 2011).
We focused on the bHLH transcription factor ASCL1 because
of its well-characterized function in neurogenesis (Guillemot
et al., 1993; Parras et al., 2004; Vierbuchen et al., 2010) and its
expression in adult NSCs/NPCs (Pastrana et al., 2009). In line
with previous reports, we found that the ASCL1 protein is ex-
pressed in the nucleus of a subset of neural stem and progenitor
cells in the adult brain (Figure S1A) and adult NPCs in culture
(Figure 2D). Ascl1 mRNA is highly expressed in activated NSCs
and NPCs freshly purified from the brain, whereas other bHLH
transcription factor mRNAs (Neurod1, Neurog1, and Myod1)
are not expressed at detectable levels in activated NSCs and
NPCs (Figure 2E). Conversely, other transcription factors whose
mRNA is expressed in NPCs (Hes1, E2a/Tcf3, Olig2, and Sox2)
(Figure 2E) have different binding motifs and/or are not known
to be involved in neurogenesis (Figure 2C). These observations
raise the possibility that ASCL1 may be the bHLH transcription
factor that functionally interacts with FOXO3 in NPCs.
FOXO3 and ASCL1 Share Targets Genome-wide in
Adult NPCs
To determine if FOXO3 and ASCL1 bind similar genes genome-
wide, we performed ASCL1 ChIP-seq in NPCs (Figure 3). ASCL1
ChIP-seq revealed18,000 ASCL1 binding sites in NPCs, corre-
sponding to6,000 unique genes (Figure 3A; Tables S4 and S5).
De novo MEME motif analysis identified the presence of the
ASCL1 consensusmotif CAGCTGat 91.8%of the ASCL1-bound
regions (E value = 2.4 3 1017208) (Figure 3B). The top ten
ASCL1-bound genes are included in Figure 3C (a complete list
of these genes and uploadable UCSC Genome Browser tracks
are available in Tables S4 and S5). ChIP-qPCR experiments
confirmed that ASCL1 is recruited to these genomic loci in
NPCs (Figure 3D) and that ASCL1 is also bound to these sites
in vivo in microdissected neurogenic niches (SVZs) (Figure 3E).
ASCL1 binding in primary cultures of adult NPCs significantly
overlaps with ASCL1 binding in NS5 cells (neural progenitor cells
derived from embryonic stem cells) as well as in the ventral telen-
cephalon in vivo (Castro et al., 2011) (Figure S3E; Table S3).
Figure 2. FOXO3 Binding Sites Are Enriched for a
bHLH Transcription Factor Motif
(A) MEME motif analysis of the 100 bp regions centered
around the 4,329 FOXO3 binding sites reveals a FOXO
consensus motif.
(B) MEME de novo motif analysis of the 200 bp region
surrounding FOXO3 ChIP-seq QuEST peaks reveals an
E-box consensus motif, which is known to be bound by
bHLH transcription factors.
(C) Table of transcription factors with their consensus
motif, expression, and known function in NPCs.
(D) ASCL1 expression in cultured NPCs. ASCL1 (green) is
expressed in >80% cultured adult NPCs, with extensive
overlap with SOX2 (red). ASCL1/SOX2 merge is shown in
the bottom right. DAPI (blue) is shown in the upper left.
Scale bar represents 25 mm.
(E) Expression of the genes encoding FOXO3, ASCL1,
and other transcription factors shown in (C) in FACS-
sorted populations of astrocytes, activated NSCs, and
neural progenitor cells (NPCs) isolated directly from
adult mouse brains. Mean ± SD of technical replicates
of one representative experiment of two independent
experiments.
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These data confirm that data sets obtained in primary cultures of
adult NPCs are relevant in vivo.
Importantly, comparison of the FOXO3 and ASCL1 ChIP-seq
data sets revealed that 70.9% of FOXO3-bound genes were
also bound by ASCL1 in NPCs (Figure 3F). In about 35% of
cases of common targets, FOXO3 and ASCL1 binding sites
were indeed within 200 bp of each other (Figure 3G, upper
panel), consistent with the percentage of E-box motif occur-
rence close to the FOXO motif (31.8%). FOXO3 and ASCL1
binding sites could also be more distant than 200 bp from
one another (Figure 3G, lower panel). To test if FOXO3 and
ASCL1 co-occur at some of their shared targets in the same
cell, we performed sequential ChIP experiments (ASCL1
ChIP-FOXO3 reChIP) in NPCs in low growth factor signaling
conditions (Figure 3H). Several genomic loci that were bound
by ASCL1 (Vac14/Mtss1l, Zbtb7c, Cd276, Cbara1, Tns3, and
Dgkg) were cobound by FOXO3, although there were also
some loci at which FOXO3 and ASCL1 cobinding could
not be detected (Ttyh2, Dll1, and Hes6) (Figure 3H). Thus,
FOXO3 and ASCL1 share targets genome-wide in primary cul-
tures of adult NPCs and can co-occur in the same cell at some
genomic loci.
FOXO3 and ASCL1 Are Enriched at Enhancer Regions
FOXO3 and ASCL1 binding occurs at promoter regions, but also
in intergenic regions and in introns (Figures 4A and S4), which are
known to contain enhancers. These observations led us to ask if
FOXO3 and ASCL1 bind to bona fide enhancers, and if regions
bound by both FOXO3 and ASCL1 are different from regions
bound by only one of these factors. Chromatin states of en-
hancers have been recently defined as enriched for H3K4me1
and depleted for H3K4me3 and H3K27me3 (Heintzman et al.,
2009; Rada-Iglesias et al., 2011). To characterize enhancers in
primary cultures of adult NPCs, we performed ChIP-seq for his-
tone marks H3K4me1, H3K4me3, and H3K27me3 (Figure 4B).
Both FOXO3 and ASCL1 binding sites were found in genomic
regions that were enriched for H3K4me1 and depleted for
H3K4me3 and H3K27me3 (Figure 4C), suggesting that FOXO3
and ASCL1 bind regions with several features of enhancers.
Interestingly, FOXO3/ASCL1 cobound regions were statistically
enriched for the H3K4me1 mark over regions bound by either
FOXO3 or ASCL1 alone (p = 7.37 3 1035 and p = 2.08 3Figure 3. Direct Targets of the Neuronal Fate Determinant ASCL1 Exte
(A) Numbers of unique Solexa reads, QuEST peaks, corresponding RefSeq genes
seq from adult NPCs.
(B) MEME de novo motif analysis of ASCL1-bound genomic loci identified by ChI
FOXO3 peaks.
(C) List of the top ten ASCL1-bound genes in adult NPCs with the highest QuES
(D) ChIP-qPCR analysis of selected ASCL1 target genes in NPCs. Mean ± SD of tw
negative control.
(E) ASCL1 ChIP-qPCR in chromatin extracts from microdissected SVZs from adu
relative to input. Neg C, negative control.
(F) Genome-wide overlap between FOXO3 target genes and ASCL1 target gene
(G) Example of genomic loci bound by both FOXO3 and ASCL1 at sites in close pro
FOXO3 binding is shown in blue, ASCL1 binding is shown in orange.
(H) FOXO3 and ASCL1 co-occupy the Vac14/Mtss1l, Zbtb7c, Cd276, Cbara1, T
ChIP-FOXO3 reChIP). Enrichment is normalized to a negative control region of th
See also Figure S3 and Tables S4, S5, and S6.1027, respectively) (Figure 4D). These data suggest that
FOXO3 and ASCL1 are enriched at enhancers, which tend to
be more lineage-specific than promoters (Heintzman et al.,
2009; Rada-Iglesias et al., 2011).
FOXO3 Inhibits ASCL1-Dependent Transcription of
Neurogenic Genes
To determine the functional consequence of FOXO3 and ASCL1
binding on gene expression, we asked if genes bound by both
FOXO3 and ASCL1 have unique characteristics compared to
genes bound by only one of these transcription factors (Figures
5A and S5). PANTHER analysis revealed that the genes bound by
both FOXO3 and ASCL1weremore highly enriched for the Notch
and Wnt signaling pathways than genes bound by FOXO3 or
ASCL1 alone (Figure 5A; Table S6). TheNotch andWnt pathways
are known to regulate the balance between NSCs and more
committed progenitors (Aguirre et al., 2010; Chapouton et al.,
2010; Imayoshi et al., 2010; Lie et al., 2005; Oishi et al., 2004).
The Notch pathway has also been shown to be critical for
ASCL1-dependent neurogenesis (Castro et al., 2006) and has
been implicated downstream of FOXO1 in myoblasts (Kitamura
et al., 2007). Together, these observations raise the possibility
that in NPCs, FOXO3 regulates ASCL1 targets involved in Notch
signaling.
We focused on Dll1 and Hes6 because these genes belong to
the Notch pathway and are well-known targets of ASCL1 in vitro
and in vivo (Castro et al., 2006). FOXO3 and ASCL1 both bind
Dll1 and Hes6 at sites that are enriched for the enhancer mark
H3K4me1 in cultured NPCs (Figure 5B). Interestingly, expression
of FOXO3 in NPCs inhibits the ability of ASCL1 to upregulate Dll1
and Hes6 in adult NPCs (Figure 5C). FOXO3 also inhibited
ASCL1-dependent expression ofDll1 andHes6 in the embryonic
stem cell-derived neural progenitor NS5 cell line (Figure 5D).
FOXO3 does not appear to restrain ASCL1-dependent transcrip-
tion by blocking the recruitment of ASCL1 to these genes: low
growth factor signaling conditions, which induce the accumula-
tion of endogenous FOXO3 into the nucleus, did not significantly
affect ASCL1 binding (Figure S6A), and, vice versa, ASCL1 bind-
ing was not drastically altered in NPCs from Foxo3/ mice
(Figure S6B). Together, these data show that FOXO3 inhibits
ASCL1-dependent induction of the Notch pathway genes Dll1
andHes6 in cultured NPCs and are consistent with the possibilitynsively Overlap with FOXO3 Targets
, unique gene symbols, and QuEST false discovery rates (FDR) for ASCL1ChIP-
P-seq reveals an E-box consensus motif that is similar to that identified around
T scores.
o independent experiments. Enrichment is calculated relative to input. Neg C,
lt mice. Mean ± SD of two independent experiments, enrichment is calculated
s.
ximity (Hes1 locus, upper panel) or at distant sites (Sema4c locus, lower panel).
ns3, and Dgkg genomic loci in the same cell. Sequential ChIP-qPCR (ASCL1
e genome. One experiment is shown.
Cell Reports 4, 477–491, August 15, 2013 ª2013 The Authors 483
Figure 4. FOXO3 and ASCL1 Are Enriched at Enhancers
(A) FOXO3 and ASCL1 bind in intergenic and intronic regions, which contain potential enhancers.
(B) Numbers of unique Solexa reads, MACS peaks, corresponding RefSeq genes, unique gene symbols, and MACS false discovery rates (FDR) for H3K4me3,
H3K27me3, and H3K4me1 ChIP from adult NPCs. N/A; not applicable.
(C) Distribution of H3K4me3, H3K27me3, and H3K4me1 at FOXO3, ASCL1 and cobound genomic regions.
(D) Genomic loci bound by both ASCL1 and FOXO3 are enriched for the H3K4me1 mark, a hallmark of enhancers.
See also Figure S4.
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Figure 5. FOXO3 Represses ASCL1-Dependent Expression of Neurogenic Genes in NPCs
(A) PANTHER analysis (selected pathways and biological processes) on genesets bound by FOXO3 only (blue), ASCL1 only (orange), and by both FOXO3 and
ASCL1 (dark green).
(B) FOXO3 binding (blue), ASCL1 binding (orange), and enrichment of the enhancer mark H3K4me1 (light green) at Dll1 and Hes6, two genes of the Notch
pathway. Note that the FOXO3 binding site in the Hes6 regulatory region has a QuEST score of 46.6, which is just under the most stringent QuEST cutoff.
(C) Expression of Dll1 and Hes6 in primary adult NPCs expressing empty vector (EV), ASCL1, FOXO3, or a combination of ASCL1+FOXO3. Mean±SEM of three
independent experiments. **p < 0.01, ***p < 0.001. One-way ANOVA, Bonferroni correction.
(D) Expression of the Notch pathway genesDll1 andHes6 in embryonic stem cell-derived NPCs (NS5 cells) expressing GFP (negative control), ASCL1, FOXO3, or
a combination of ASCL1+FOXO3. Mean ± SD of one experiment conducted in triplicate. ***p < 0.001, One-way ANOVA, Bonferroni correction.
See also Figures S5 and S6.that FOXO3 acts by preventing ASCL1-dependent transcription
rather than binding.
FOXO3 Inhibits ASCL1-Dependent Neurogenesis in
Adult NPCs and Neuronal Conversion of Fibroblasts
To determine if the inhibition of ASCL1-dependent expression of
neurogenic genes by FOXO3 had physiological consequences,
we first tested if FOXO3 impacts ASCL1’s ability to promote neu-
rogenesis in adult NPCs. Consistent with previous reports in
other cellular systems (Farah et al., 2000; Vierbuchen et al.,
2010), ASCL1 expression also potently induced neurogenesis
in adult NPCs (Figure 6A). Importantly, FOXO3 significantly
decreased the ability of ASCL1 to induce neurogenesis (Fig-
ure 6A). However, the impact of FOXO3 on neurogenesis is
more pronounced than that on gene expression, suggestingthat FOXO3 could also repress neurogenesis via additional tar-
gets or mechanisms.
Expression of ASCL1 together with other proneural transcrip-
tion factors (MYT1L and/or BRN2) was recently shown to directly
reprogram fibroblasts into iNs (Vierbuchen et al., 2010; Pang
et al., 2011). We assessed the effect of FOXO3 on the ability of
ASCL1 to directly convert mouse embryonic fibroblasts (MEFs)
into iNs (Figure 6B). As expected, ASCL1 and MYT1L efficiently
induced the generation of TUJ1-positive iNs in MEFs (Fig-
ure 6B). Interestingly, ectopic expression of FOXO3 significantly
decreased the ability of ASCL1/MYT1L to reprogram MEFs into
TUJ1-positive iNs (Figure 6B). By contrast, expression of an
inactive form of FOXO3 that lacks the DNA binding domain
did not significantly affect ASCL1/MYT1L-dependent iN con-
version (Figure 6B). These results indicate that FOXO3 bindingCell Reports 4, 477–491, August 15, 2013 ª2013 The Authors 485
Figure 6. FOXO3 Restrains ASCL1 from Promoting Neurogenesis in Adult NPCs and Reprogramming Mouse Embryonic Fibroblasts into
Neurons
(A) Percentage of DCX-positive cells (new neurons) in adult NPCs infected by lentiviruses expressing GFP, ASCL1, FOXO3, or a combination of
ASCL1+FOXO3. Mean ± SEM of two independent experiments. **p < 0.01. One-way ANOVA, Bonferroni correction. Right panel: representative images. Scale
bar represents 20 mm.
(B) Percentage of TUJ1-positive cells (iNs) in mouse embryonic fibroblasts infected by lentiviruses expressing GFP, ASCL1+MYT1L, ASCL1+MYT1L+FOXO3, or
ASCL1+MYT1L+inactive FOXO3. Mean ± SEM of three independent experiments. **p < 0.01. One-way ANOVA, Bonferroni correction. Right panel: represen-
tative images. Scale bar represents 20 mm.antagonizes ASCL1’s ability to promote the direct neuronal con-
version of fibroblasts.
Foxo3 Loss Results in Increased Neurogenesis
We asked if FOXO3 impacts neurogenesis in vivo. Costaining of
adult mouse brain sections reveals that FOXO3 and ASCL1 are
colocalized in neurogenic niches (SVZs) in a subset of cells
that are marked with SOX2, a marker of neural stem/progenitor486 Cell Reports 4, 477–491, August 15, 2013 ª2013 The Authorscells (Figures 7A and S1A). FOXO3 is localized in the nucleus
in a subset of these cells, though not all (Figures 7A and S1A),
indicating that active FOXO3 and ASCL1 coexist in some, but
not all, neural stem and/or progenitor cells in the adult brain
in vivo. We next assessed neurogenesis in adult Foxo3/ and
Foxo3+/+ mice by injecting 5-ethynyl-20-deoxyuridine (EdU) and
costaining sections of the olfactory bulb, the region where new
neurons generated in the SVZ migrate to, with EdU and DCX, a
Figure 7. Foxo3 Deficiency Increases Adult Neurogenesis
(A) FOXO3 and ASCL1 expression in the adult SVZ in vivo. Green, FOXO3; red, ASCL1; white, SOX2 (a marker of neural stem/progenitor cells). Scale bar
represents 20 mm. Arrows show ASCL1-expressing cells.
(B) Foxo3 deficiency results in increased neurogenesis in the olfactory bulb of adult mice. Percentage of EdU+DCX+ cells (new neurons) in the olfactory bulb in
adult (4 months old) Foxo3+/+ and Foxo3/ mice. Mean ± SEM of n = 4 mice per group. *p < 0.05, Student’s t test.
(C) Dll1 and Hes6 expression in Foxo3+/+ and Foxo3/ in vivo. Taqman RT-qPCR analysis of Dll1 and Hes6 expression in activated NSCs and NPCs
freshly isolated from adult mouse brains by FACS. Mean ± SEM of n = 4 mice (two mice in two independent FACS experiments). *p < 0.05, one-sided Wilcoxon
exact test.marker of newly formed neurons. Foxo3 deficiency led to a
significant increase in the production of new neurons in the
olfactory bulbs of adult mice (Figure 7B, Student’s t test, p <
0.05). Hes6 expression was slightly increased in activated
NSCs and NPCs that were freshly purified by FACS from
Foxo3/ mice compared to Foxo3+/+ mice (Figure 7C, one-sided Wilcoxon exact test, p < 0.05), although Dll1 expression
was not significantly affected (Figure 7C). These results are
consistent with the possibility that FOXO3 may antagonize the
ability of ASCL1 to induce neurogenic genes in vivo, although
other targets or mechanisms may mediate the effect of FOXO3
on neurogenesis.Cell Reports 4, 477–491, August 15, 2013 ª2013 The Authors 487
DISCUSSION
Interaction between a Forkhead Transcription Factor
and a bHLH ‘‘Master Regulator’’ of Cell Fate
Our study uses ultra-high-throughput sequencing technologies
to identify FOXO3 and ASCL1 targets in primary cultures of adult
NPCs and reveals that FOXO3 and ASCL1 overlap genome-wide
and are particularly enriched at enhancers of genes involved the
Wnt and Notch signaling pathways. Our study also provides
evidence that FOXO3 inhibits the ability of ASCL1 to induce neu-
rogenesis and direct neuronal conversion. These findings have
implications in other systems because bHLH master regulators
are pivotal for the determination of many cell lineages. The bind-
ing of two other Forkhead transcription factors, FOXO1 and
FOXH1, has been found to overlap with that of the bHLH regu-
lator E2A in B cells and human embryonic stem cells, respec-
tively (Lin et al., 2010; Yoon et al., 2011), although the exact
bHLH transcription factor that is involved is not known. Thus,
binding in close proximity to bHLH transcription factors may
be a general feature of Forkhead transcription factors. As several
Forkhead transcription factors are known to act as ‘‘pioneer
factors’’ to open chromatin (Zaret and Carroll, 2011), these
factors may help provide an open chromatin context for
lineage-specific transcription factors to activate transcription
of differentiation genes. Transcription factors of the bHLH family
are particularly powerful at eliciting direct reprogramming (Vier-
buchen and Wernig, 2011). Our discovery that a Forkhead tran-
scription factor and a bHLH transcription factor genomically and
functionally interact also has implications for direct reprogram-
ming. The potential applications of direct reprogramming in
cellular therapies or drug screening are limited by the relatively
low efficiency of this process, especially in human cells (Pang
et al., 2011). Thus, identifying molecular barriers (such as
FOXO) that limit direct reprogramming should be a key step in
improving the efficiency of this process.
Mechanisms of Inhibition of ASCL1-Dependent
Neurogenesis by FOXO3
Our finding that FOXO3 inhibits ASCL1-dependent neurogenesis
is consistent with the observation that inhibition of PDK1-AKT
signaling, which results in FOXO activation, reduces neurogene-
sis in NPCs, whereas a constitutively active form of AKT or loss of
PTEN, which leads to FOXO inhibition, enhances neurogenesis
(Gregorian et al., 2009; Oishi et al., 2009). Interestingly, ASCL1/
MASH1 protein stabilization has been shown to mediate at least
in part the positive effect of AKT signaling on neurogenesis (Oishi
et al., 2009). Thus, it is conceivable that the PI3K-AKT signaling
pathway coordinates ASCL1 stabilization with ASCL1 activation
(via inhibition of the repressive effect of FOXO3 on ASCL1) to
achieve a more potent induction of neurogenesis.
The exact transcriptional mechanisms by which FOXO3 in-
hibits ASCL1-dependent gene expression remain to be estab-
lished. FOXO3 and ASCL1 cobinding could not be detected by
sequential ChIP at the Dll1 and Hes6 loci. Furthermore, FOXO3
and ASCL1 do not appear to physically interact (A.E.W. and
A.B., data not shown). It remains possible that negative results
in these cobinding experiments are due to technical limitations.
Nevertheless, these results may also suggest a ‘‘displacement488 Cell Reports 4, 477–491, August 15, 2013 ª2013 The Authorsmodel’’ to explain FOXO3’s ability to inhibit ASCL1 dependent
transcription, in which either FOXO3 or ASCL1 could bind to
the Dll1 and Hes6 loci, but these transcription factors could not
be bound at the same time. FOXO3 may also function by inhibit-
ing the recruitment of ASCL1 coactivators at neurogenic genes.
Alternatively, FOXO3 may recruit a repressive complex in the
presence of ASCL1. Part of the effects of FOXO3 on ASCL1-
dependent transcription may also be indirect: for example,
FOXO3 may limit neurogenesis as a consequence of promoting
stem cell quiescence. Indeed, ASCL1 is required for normal NSC
proliferation (Castro et al., 2011), while also functioning as a
positive regulator of neurogenesis (Parras et al., 2004). Thus,
FOXO3 may inhibit neurogenesis as a consequence of prevent-
ing ASCL1-dependent proliferation of committed progenitors.
How FOXO3 and ASCL1 interact in vivo, and whether FOXO3
restrains neurogenesis in the adult brain by inhibiting ASCL1-
dependent transcription, is still unclear. Furthermore, the func-
tion of ASCL1 in adult neurogenesis has not been established.
We note that the expression of the ASCL1 target gene Hes6
was only slightly increased in Foxo3/ NSCs in vivo, and that
Dll1 expression was not significantly changed in these mice.
Thus, other target genes may function downstream of FOXO3
to regulate neurogenesis in vivo. It will be interesting to further
dissect the genetic interactions between FOXO3 and ASCL1,
aswell as their target genes, in stem cell homeostasis and neuro-
genesis in vivo.
Stemness and Aging
Our data raise the possibility that FOXO3 maintains a stem/
progenitor cell state in part by restraining master regulators of
differentiated cell fates. Consistent with this model, loss of
Foxo1, Foxo3, and Foxo4 in the brain results in increased neuro-
genesis, followed by NSC depletion in adulthood (Paik et al.,
2009; Renault et al., 2009). Recent evidence has also implicated
FOXO in inhibiting premature differentiation. In hydra, FOXO
depletion leads to enhanced terminal differentiation of foot
cells, whereas FOXO overexpression promotes the expression
of stemness genes (Boehm et al., 2012). FOXO family members
have also been implicated in human embryonic stem cell (ESC)
pluripotency. FOXO1 is necessary for human ESC pluripotency
(Zhang et al., 2011) and FOXO4 has been shown to be required
for proteasome activity, a key component of the pluripotency of
these cells (Vilchez et al., 2012). FOXO4 has also been found
to be necessary for the neural differentiation of human ESCs
(Vilchez et al., 2013), which contrasts with our findings that adult
Foxo3/ mice exhibit increased neurogenesis and that triple
Foxo knockout mice also show enhanced neurogenesis postna-
tally (Paik et al., 2009). Different FOXO family members may act
at different points in cellular commitment: the competence of
the progenitor pool versus differentiation per se. Alternatively,
pluripotent embryonic stem cells may have different require-
ments from more committed lineage-specific stem cells.
FOXO transcription factors are conserved regulators of
longevity (Kenyon, 2010). Our discovery of target genes shared
between FOXO and bHLH factors raises the exciting possibility
that bHLH transcription factors and Notch signaling may, by
association, also be involved in longevity. In this context, it is
interesting to note that heterochronic parabiosis, the junction
by blood circulation of an old mouse and a young mouse, re-
stores Notch signaling and the regenerative capacity of muscle
and neural stem cells in old mice (Conboy et al., 2005; Villeda
et al., 2011). The concerted action of FOXO and ASCL1 in the
balance between stem cell maintenance and differentiation
might play an important role in tissue homeostasis and longevity.
EXPERIMENTAL PROCEDURES
Animals
FoxO3+/+ and FoxO3lox/lox mice were a kind gift from Dr. Ron DePinho (Dana
Farber Cancer Center, Boston). Wild-type FVB/N animals were purchased
from Charles River. All animals were treated and housed according to the
Guide for Care and Use of Laboratory Animals. All experimental procedures
were approved by Stanford’s Administrative Panel on Laboratory Animal
Care (APLAC) and were in accordance with institutional and national
guidelines.
Mouse NPC Cultures
Adult (12-week-old) mouse NPCs were isolated as previously described
(Renault et al., 2009). Briefly, whole-mouse forebrains were homogenized
and incubated for 30 min in HBSS (Invitrogen) with 1 U/ml DispaseII (Roche),
250 U/ml DNaseI (Sigma), and 2.5 U/ml Papain (Worthington) at 37C. After
mechanical dissociation, cells were purified by sequential 25% and 65% Per-
coll (Amersham) gradients. Cells were cultured in high growth factor signaling
conditions: Neurobasal A (Invitrogen) medium supplemented with penicillin/
streptomycin/glutamine (Invitrogen), 2% B27 (Invitrogen), and 20 ng/ml each
of FGF2 (Peprotec) and EGF (Peprotec). To induce FOXO3 nuclear accumula-
tion, cells were incubated in low growth factor signaling conditions: Neuro-
basal A medium supplemented with penicillin/streptomycin/glutamine and
2% B27 for 4 hr, followed by a 1.5 hr incubation with 20 mM LY294002 (LY,
Calbiochem), a specific PI3K inhibitor, to inhibit residual growth factor
signaling. For differentiation, NPCs were plated at 105 cells/ml on poly-D-
lysine-coated plates and incubated in differentiation conditions (Neurobasal
Amedium supplemented with penicillin/streptomycin/glutamine, 2%B27 sup-
plement, and 0.5% [unless specifically noted] fetal bovine serum [Invitrogen])
for 0, 2, or 7 days, and differentiation media was replaced every other day.
ChIP-Seq
For ChIP-seq, primary NPCs were isolated and amplified in culture for a
limited number of passages (four to nine), and ChIP experiments were per-
formed as described (Renault et al., 2009) (see Extended Experimental Proce-
dures). For FOXO3 and ASCL1 ChIP-seq, 80–100 3 106 cells were used to
generate Illumina single-end libraries. For H3K4me3 and H3K27me3 ChIP-
seq, 10–20 3 106 cells were used. Libraries were generated according to
the manufacturer’s instructions (Illumina). Twenty-five base pair reads were
generated on an Illumina Genome Analyzer II and subsequently mapped to
the 2007 release of the mouse genome (mm9). Peak calling was performed
using QuEST 2.4 (Valouev et al., 2008). The highest stringency QuEST param-
eters for transcription factors were used for FOXO3 and ASCL1 ChIP-seq (fold
enrichment >50, bandwidth = 30). For histone mark ChIP-seq, Fastq files for
ChIP-seq data sets were filtered using the FASTX-Tookit (http://hannonlab.
cshl.edu/fastx_toolkit/index.html) and reads with phred scores less than 15
on 85% of their sequence were filtered. Histone modification sites from the
filtered and aligned reads were identified using MACS (version macs2 2.0.8)
(Zhang et al., 2008) at a FDR threshold 0.01 with a broad setting that enables
linking nearby enriched regions (linking cutoff = 0.1). RefSeq genes, genomic
features and corresponding coordinates were downloaded from the UCSC
Genome Browser.
Lentiviral Infections of NPCs and Neurogenesis Assays
For lentiviral infection, NPCs were plated on poly-D-lysine at 50,000 cells/cm2
in high growth-factor-signaling conditions. Sixteen hours after plating, cells
were infected with lentiviral-conditioned supernatents at a 1:2 ratio (lenti-
virus-conditioned supernatent:NPC medium). Twenty-four hours postinfec-
tion, fresh proliferating medium containing 2 mg/ml doxycycline (Sigma) wasadded to induce expression of transduced genes. For gene expression anal-
ysis, total RNA was collected 6 hr postinduction and RT-qPCRs were
performed as described in the Extended Experimental Procedures. For
neurogenesis assays, cells were treated with 2 mg/ml doxycycline for 24 hr
and then switched to differentiation conditions containing 2 mg/ml doxycycline.
The media was changed after 2 days, and samples were collected after
4 days of differentiation. For neurogenesis assays, cells were fixed and
immunocytochemistry was performed as described in the Extended Experi-
mental Procedures with the following antibodies: DCX (Santa Cruz Biotech-
nology SC-8066, 1:200), Flag (Sigma F7425, 1:1,000), HA (Roche 12CA5
#11867423001, 1:200), and TUJ1 (Covance PRB-435P, 1:1,000).
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